The metabolic adaptation evoked by arginine enhances the effect of radiation in brain metastases Journal Article


Authors: Marullo, R.; Castro, M.; Yomtoubian, S.; Nieves Calvo-Vidal, M.; Revuelta, M. V.; Krumsiek, J.; Cho, A.; Morgado, P. C.; Yang, S.; Medina, V.; Roth, B. M.; Bonomi, M.; Keshari, K. R.; Mittal, V.; Navigante, A.; Cerchietti, L.
Article Title: The metabolic adaptation evoked by arginine enhances the effect of radiation in brain metastases
Abstract: Selected patients with brain metastases (BM) are candidates for radiotherapy. A lactatogenic metabolism, common in BM, has been associated with radioresistance. We demonstrated that BM express nitric oxide (NO) synthase 2 and that administration of its substrate l-arginine decreases tumor lactate in BM patients. In a placebo-controlled trial, we showed that administration of l-arginine before each fraction enhanced the effect of radiation, improving the control of BM. Studies in preclinical models demonstrated that l-arginine radiosensitization is a NO-mediated mechanism secondary to the metabolic adaptation induced in cancer cells. We showed that the decrease in tumor lactate was a consequence of reduced glycolysis that also impacted ATP and NAD+ levels. These effects were associated with NO-dependent inhibition of GAPDH and hyperactivation of PARP upon nitrosative DNA damage. These metabolic changes ultimately impaired the repair of DNA damage induced by radiation in cancer cells while greatly sparing tumor-infiltrating lymphocytes. Copyright © 2021 The Authors, some rights reserved;
Keywords: cytology; metabolism; pathology; brain; tumors; brain metastasis; diseases; cancer cells; arginine; cells; nitric oxide; radioresistance; controlled trial; dna damages; l-arginine; metabolic adaptation; radio-sensitization; nad +; nitric oxide synthases
Journal Title: Science Advances
Volume: 7
Issue: 45
ISSN: 2375-2548
Publisher: Amer Assoc Advancement Science  
Date Published: 2021-11-05
Start Page: eabg1964
Language: English
DOI: 10.1126/sciadv.abg1964
PROVIDER: scopus
PMCID: PMC8570607
PUBMED: 34739311
DOI/URL:
Notes: Article -- Export Date: 1 December 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors